Parent attitudes about school requirements for human papillomavirus vaccine in high-risk communities of Los Angeles, California

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 7, 2011, Pages 1421-1429

  Robitz, Rachel ^a   Gottlieb, Sami L ^a   De Rosa, Christine J ^b   Guerry, Sarah L ^b   Liddon, Nicole ^a   Zaidi, Akbar ^a   Walker, Susan ^b   Smith, Jennifer S ^c,d   Brewer, Noel T ^c,d   Markowitz, Lauri E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Los Angeles County Department of Public Health   (United States)

^c IL   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DRUG EFFICACY; ETHNICITY; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HISPANIC; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PARENTAL ATTITUDE; PRIORITY JOURNAL; TELEPHONE; UNITED STATES; UTERINE CERVIX CANCER;

ADOLESCENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOS ANGELES; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; SCHOOLS; UTERINE CERVICAL NEOPLASMS;

EID: 79960097870     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1236     Document Type: Article

References (44)

1. Food and Drug Administration. FDA approves new vaccine for cervical cancer prevention. [cited 2010 Oct 27]. Available from: www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm187048.htm.
2. Food and Drug Administration. FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. [cited 2010 Oct 27]. Available at: www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/2006/ucm108666.htm.
3. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048-56.
4. Greer CE, Wheeler CM, Ladner MB, Beutner K, Coyne MY, Liang H, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995;33:2058-63.
5. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007;56:1-24.
6. National Cancer Institute. Surveillance epidemiology and end results. [cited 2011 Jan 31]. Available from: seer.cancer.gov/statfacts/html/cervix.html.
7. Ault KA. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007;369:1861-8. (Pubitemid 46829356)
8. Flannery B, Schrag S, Bennett NM, Lynfield R, Harrison LH, Reingold A, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 2004;291:2197-203. (Pubitemid 38608168)
9. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med 2008;359:821-32.
10. Task Force on Community Preventive Services. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med 2000;18:92-6.
11. Averhoff F, Linton L, Peddecord KM, Edwards C, Wang W, Fishbein D. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health 2004;94:978-84. (Pubitemid 38691543)
12. Morita JY, Ramirez E, Trick WE. Effect of a school-entry vaccination requirement on racial and ethnic disparities in hepatitis B immunization coverage levels among public school students. Pediatrics 2008;121:e547-52.
13. Colgrove J. The ethics and politics of compulsory HPV vaccination. N Engl J Med 2006;355:2389-91. (Pubitemid 44903743)
14. Gostin LO, DeAngelis CD. Mandatory HPV vaccination: public health vs private wealth. JAMA 2007;297:1921-3. (Pubitemid 46707847)
15. Colgrove J, Abiola S, Mello MM. HPV vaccination mandates - law-making amid political and scientific controversy. N Engl J Med 2010;363:785-91.
16. Charo RA. Politics, parents, and prophylaxis-mandating HPV vaccination in the United States. N Engl J Med 2007;356:1905-8. (Pubitemid 46740299)
17. Haber G, Malow RM, Zimet GD. The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol 2007;20:325-31. (Pubitemid 350235971)
18. Saul S, Pollack A. Furor on rush to require cervical cancer vaccine. 2007. New York Times.
19. National Conference of State Legislatures. HPV vaccine: state legislation and statutes. [cited 2010 Oct 27]. Available from: www.ncsl.org/default.aspx? tabid=14381.
20. Salmon DA, Omer SB, Moulton LH, Stokley S, DeHart MP, Lett S, et al. Exemptions to school immunization requirements: the role of school-level requirements, policies, and procedures. Am J Public Health 2005;95:436-40. (Pubitemid 40315119)
21. Center for Disease Control and Prevention. ACIP recommends HPV vaccination. [cited 2010 Oct 2007]. Available from: http://www.cdc.gov/media/ transcripts/t060629.htm.
22. Medi-Cal. HPV vaccine update. [cited 2010 Oct 27] Available at: http://www.cdph.ca.gov /programs/ immunize/Documents/ gm20070901.doc.
23. Dittus P, DeRosa C, Ethier K, Chung E, Martinez S, Wong K, et al. Project connect: positive effects of a multi-level social-ecological intervention for adolescents. Paper presented at: 2008 National STD Prevention Conference, Chicago, IL.
24. Keck School of Medicine at USC: Cancer surveillance program. [cited 2011 Feb 16]. Available from: http://keck.usc.edu/en/Education/Academic-Department- and-Divisions/Department-of-Preventive-Medicine/Divisions/Epidemiology/Research/ Cancer-Surveillance-Program/Cancer-Statistics.aspx.
25. Los Angeles Unified School District. [cited 2011 Mar 3]. Available from: http://www.lausd.net.
26. Guerry SL, De Rosa CR, Markowitz LE, Walker S, Liddon N, Kerndt PR, et al. HPV vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011;29:2235-41.
27. Yeganeh N, Curtis D, Kuo A. Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates. Vaccine 2010;28:4186-91.
28. Watts LA, Joseph N, Wallace M, Rauh-Hain JA, Muzikansky A, Growdon WB, et al. HPV vaccine: a comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol 2009;112:577-82.
29. Centers for disease control and prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2008. MMWR 2009;58:997-1001.
30. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010;171:357-67.
31. Centers for disease control and prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. MMWR 2010;59:1018-23.
32. National alliance for Hispanic health. Quality health services for Hispanics: The cultural competency component. [cited 2010 Oct 27]. Available from: www.hrsa. gov/culturalcompetence/quality-healthservices/ QualityHealthServicesforHispanics.pdf.
33. Cuellar I, Arnold B, Maldonado R. Acculturation rating-scale for Mexican-Americans - II: a revision of the original arsma scale. Hispanic J Behav Sci 1995;17:275-304.
34. Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR. Race and trust in the health care system. Public Health Rep 2003;118:358-65. (Pubitemid 36828340)
35. Crawley LM. African-American participation in clinical trials: situating trust and trustworthiness. J Natl Med Assoc 2001;93:14S-7S.
36. Horn L, Howard C, Waller J, Ferris DG. Opinions of parents about school-entry mandates for the human papillomavirus vaccine. J Low Genit Tract Dis 2010;14:43-8.
37. Smith JS, Brewer NT, Chang Y, Liddon N, Guerry S, Pettigrew E, et al. Acceptability of school requirements for human papillomavirus vaccine. Paper presented at: 2009 Annual Meeting of the American Public Health Association, Philadelphia, PA.
38. Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther 2007;82:760-3. (Pubitemid 350114823)
39. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidem Biom Prev 2009;18:363-72.
40. Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 2000;284:3145-50. (Pubitemid 32039077)
41. Omer SB, Pan WK, Halsey NA, Stokley S, Moulton LH, Navar AM, et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA 2006;296:1757-63. (Pubitemid 44550031)
42. Curtin R, Presser S, Singer E. The effects of response rate changes on the index of consumer sentiment. Public Opin Quart 2000;64:413-28. (Pubitemid 33241089)
43. Keeter S, Miller C, Kohut A, Groves RM, Presser S. Consequences of reducing nonresponse in a national telephone survey. Public Opin Quart 2000;64:125-48.
44. National Vaccine Advisory Committee. Mandates for adolescent immunizations: recommendations from the National Vaccine Advisory Committee. Am J Prev Med 2008;35:145-51.